Each tablet contains:
|| 40 mg
|Pyridoxine (Vit. B6)
|| 60 mg
|(as hydrochloride 72.7 mg)
|Cyanocobalamin (Vit. B12)
Milga tablets combines three components that together have a potent effect on the remedy of inflammatory and degenerative diseases of nerves and loco motor organs, also Milga aids in the alleviation of associated pain on account of its analgesic, antiallergic and circulation-promoting properties.
Benfotiamine is a lipid-soluble form of thiamine (vitamin B-1), it is also designated as antineuritic vitamin. In its phosphorylated form (TPP) as carboxylase, it regulates the breakdown of carbohydrates and is used against acidotic metabolic disturbances. Pyridoxine (Vitamin B6) regulates protein, fat and carbohydrate breakdown. Its neurotropic effect is used, for example, in isonicotinic acid hydrazide therapy for the avoidance of neuritides. Its effects on the brain stem attenuate extrapyramidal symptoms.
Cyanocobalamin (Vitamin B12) is essential for cell metabolism, normal blood formation and functioning of the nervous system. It catalyses biological nucleic acid synthesis, and consequently the structure of new cell nuclei. Owing to the complementarities of its components, the vitamin combination in Milga, with its causal effect and good tolerance, has a wide range of uses far exceeding the treatment of acute and chronic neurological diseases.
If hypersensitivity towards any of the ingredients is suspected, otherwise there are no known contraindications
In rare individual cases there may be allergic hypersensitivity reactions.
There are interactions with INH, D-penicillamine, cycloserine theophylline & MAOIs. Therapeutic doses of vitamin B6 may reduce the effectiveness of L-dopa & hydralazine.
No special precautions are required but doses of pyridoxine higher than 200mg over a long period of time should be avoided.
Pack of 1 or 2 blisters each of 10 tablets.